AG 879

Discontinued Product

2617 has been discontinued.

View all Trk Receptors products.
说明: TrkA inhibitor
别名: Tyrphostin AG 879
化学名: (2E)-3-[3,5-Bis(1,1-dimethylethyl)-4-hydroxyphenyl]-2-cyano-2-propenethioamide
纯度: ≥99% (HPLC)
说明书
引用文献 (1)
评论
文献 (3)

生物活性 for AG 879

AG 879 is an inhibitor of the tyrosine kinase activity of nerve growth factor (NGF) TrkA. Decreases cellular proliferation in human muscular sarcoma cell lines. Also inhibits ErbB2 and VEGFR-2 (IC50 values are approximately 1 μM for both).

技术数据 for AG 879

分子量 316.46
公式 C18H24N2OS
储存 Store at -20°C
纯度 ≥99% (HPLC)
CAS Number 148741-30-4
PubChem ID 5487525
InChI Key LCUMYVYIHXYBIA-FOWTUZBSSA-N
Smiles CC(C)(C)C1=CC(/C=C(C#N)/C(N)=S)=CC(C(C)(C)C)=C1O

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

产品说明书 for AG 879

分析证书/产品说明书
选择另一批次:

按产品操作查看相关产品

查看全部 Trk Receptor Inhibitors

关键词: AG 879, AG 879 supplier, AG879, tyrosine, kinase, inhibitors, ErbB2, VEGFR-2, EGFR, Flk-1, nerve, growth, factors, inhibits, NGF, TrkA, Tyrphostin, AG, 879, Trk, Receptors, VEGFR, 2617, Tocris Bioscience

1 篇 AG 879 的引用文献

引用文献是使用了 Tocris 产品的出版物。 AG 879 的部分引用包括:

Ledonne et al (2015) Neuregulin 1 signalling modulates mGluR1 function in mesencephalic dopaminergic neurons. Mol Psychiatry 20 959 PMID: 25266126


AG 879 的评论

目前没有该产品的评论。 Be the first to review AG 879 and earn rewards!

Have you used AG 879?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Depression Poster

Depression Poster

Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.

Huntington's Disease Poster

Huntington's Disease Poster

Huntington's disease (HD) is a severe monogenic neurodegenerative disorder, which is characterized by the prevalent loss of GABAergic medium spiny neurons (MSN) in the striatum. This poster summarizes the effects of mutant huntingtin aggregation implicated in the pathology of HD, as well as highlighting the use of iPSCs for HD modeling.

Parkinson's Disease Poster

Parkinson's Disease Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.